Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions.
[en] Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded dramatically over the last years, thanks to the developments and improvements of devices and imaging techniques, along with the increasing expertise of operators. Imaging, in particular echocardiography, is pivotal during patient selection, procedural monitoring, and follow-up. The imaging assessment of patients undergoing transcatheter interventions places demands on imagers that differ from those of the routine evaluation of patients with SHD, and there is a need for specific expertise for those working in the cath lab. In the context of the current rapid developments and growing use of SHD therapies, this document intends to update the previous consensus document and address new advancements in interventional imaging for access routes and treatment of patients with aortic stenosis and regurgitation, and mitral stenosis and regurgitation.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Agricola, Eustachio ; Cardiovascular Imaging Unit, Cardio-Thoracic-Vascular Department, IRCCS San Raffaele Scientific Institute, via Olgettina 60, Milan 20132, Italy ; Vita-Salute San Raffaele University, via Olgettina 58, Milan 20132, Italy
Ancona, Francesco ; Cardiovascular Imaging Unit, Cardio-Thoracic-Vascular Department, IRCCS San Raffaele Scientific Institute, via Olgettina 60, Milan 20132, Italy
Bartel, Thomas; Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, 26th Street, Dubai, United Arab Emirates
Brochet, Eric; Cardiology Department, Hopital Bichat, 46 rue Huchard, Paris 75018, France
Dweck, Marc; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4SB, UK
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation ; Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy
Mahmoud-Elsayed, Hani; Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt
Marsan, Nina Ajmone; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Maurovich-Hovart, Pal; Medical Imaging Centre, Semmelweis University, Budapest, Hungary
Monaghan, Mark; King's College Hospital, London, UK
Pontone, Gianluca ; Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy
Sade, Leyla Elif ; University of Pittsburgh-Heart & Vascular Institute UPMC, 200 Lothrop St Ste E354.2, Pıttsburgh, PA 15213, USA ; Cardiology Department, Baskent University, Ankara, Turkey
Swaans, Martin; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
Von Bardeleben, Ralph Stephan ; Department of Cardiology, Heart and Vascular Center, Unimedizin Mainz, Germany
Zamorano, Jose-Luis; University Hospital Ramon y Cajal, Madrid, Spain
Popescu, Bogdan A; Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila' -Euroecolab, Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C. C. Iliescu', Bucharest, Romania
Cosyns, Bernard; Cardiology Department, Centrum voor Hart en Vaatziekten (CHVZ), Universitair ziekenhuis Brussel, Brussels, Belgium
Donal, Erwan ; Cardiologie, CHU de RENNES, LTSI UMR1099, INSERM, Universite´ de Rennes-1, Rennes, France
Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions.
Conflict of interest: E.A.: speaker and proctoring fees, research and educational grant from Philips, Edwards, Abbott, GE, and Siemens. E.B.: Proctoring fees from Abbott. M.D.: speaker fees from Pfizer and have participated on advisory boards for Novartis. F.F.: speaker's fees from Philips. P.M.-H.: Shareholder of Neumann Medical Ltd. M.S.: lecturer/proctor for Abbott Vascular, Boston Scientific, Philips Healthcare, and Bioventrix inc. R.S.V.B.: Trials (un-paid): IIT IZKS University of Go¨ttingen, Abbott Vascular, Bioventrix, Boston Scientific, Edwards Lifesciences, Medtronic; Speaker/ Advisory: Abbott Lifesciences, Bioventrix, Boston Scientific, Cardiac Dimensions, Edwards Lifesciences, and Philips. J.-L.Z.: research grants from Abbott. Speaker fee Daichii Sankio, Pfizer. B.A.P.: research grants and lecture fees from GE Healthcare and Hitachi-Aloka.
Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F, et al. The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. Eur Hear J Cardiovasc Imaging 2021;22:471-9.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43(7):561-632.
Waterston D. XII.-the development of the heart in man. Earth Env Sci Trans R Soc Edinb 1919; 52:257-302.
Faletra FF, Leo LA, Paiocchi VL, Schlossbauer SA, Pedrazzini G, Moccetti T, et al. Revisiting anatomy of the interatrial septum and its adjoining atrioventricular junction using noninvasive imaging techniques. J Am Soc Echocardiogr 2019;32:580-92.
Faletra FF, Leo LA, Paiocchi V, Schlossbauer S, Narula J, Ho SY. Multimodality imaging anatomy of interatrial septum and mitral annulus. Heart 2021;107:277-81.
Ho SY, McCarthy KP, Faletra FF. Anatomy of the left atrium for interventional echocardiography. Eur J Echocardiogr 2011;12:i11-5.
Brockenbrough EC, Braunwald E, Ross J. Transseptal left heart catheterization. Circulation 1962;25:15-21.
Smelley MP, Shah DP, Weisberg I, Kim SS, Lin AC, Beshai JF, et al. Initial experience using a radiofrequency powered transseptal needle. J Cardiovasc Electrophysiol 2010; 21:423-7.
Rogers JH, Stripe BR, Singh GD, Boyd WD, Fan D, Smith TWR. Initial clinical experience with the FlexPoint Steerable Transseptal Needle in left-sided structural heart procedures. Catheter Cardiovasc Interv 2018;92:792-6.
Yoon S-H, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol 2017;70:2752-63.
Hensey M, Murdoch DJ, Sathananthan J, Alenezi A, Sathananthan G, Moss R, et al. First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system. EuroIntervention 2019;14:e1553-5.
Cahill TJ, Chen M, Hayashida K, Latib A, Modine T, Piazza N, et al. Transcatheter aortic valve implantation: current status and future perspectives. Eur Heart J 2018;39: 2625-34.
Claessen BE, Tang GHL, Kini AS, Sharma SK. Considerations for optimal device selection in transcatheter aortic valve replacement: a review. JAMA Cardiol 2021;6:102-12.
Bourantas CV, van Mieghem NM, Soliman O, Campos CAM, Iqbal J, Serruys PW. Transcatheter aortic valve update 2013. EuroIntervention 2013;9:S84-90.
Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol 2018; 71:1360-78.
Sharma SK, Rao RS, Chandra P, Goel PK, Bharadwaj P, Joseph G, et al. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study. EuroIntervention 2020;16: 421-9.
Fontana GP, Bedogni F, Groh M, Smith D, Chehab BM, Garrett HE, et al. Safety profile of an intra-annular self-expanding transcatheter aortic valve and next-generation low-profile delivery system. JACC Cardiovasc Interv 2020;13:2467-78.
Seiffert M, Bader R, Kappert U, Rastan A, Krapf S, Bleiziffer S, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv 2014;7:1168-74.
Abdel-Wahab M, Landt M, Neumann F-J, Massberg S, Frerker C, Kurz T, et al. 5-year outcomes after TAVR with balloon-expandable versus self-expanding valves. JACC Cardiovasc Interv 2020;13:1071-82.
Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017;30:372-92.
Zamorano J, Gonçalves A, Lancellotti P, Andersen KA, González-Gómez A, Monaghan M, et al. The use of imaging in new transcatheter interventions: an EACVI review paper. Eur Hear J Cardiovasc Imaging 2016;17:835-835.
Witberg G, Codner P, Landes U, Schwartzenberg S, Barbanti M, Valvo R, et al. Effect of transcatheter aortic valve replacement on concomitant mitral regurgitation and its impact on mortality. JACC Cardiovasc Interv 2021;14:1181-92.
Hahn RT, Saric M, Faletra FF, Garg R, Gillam LD, Horton K, et al. Recommended standards for the performance of transesophageal echocardiographic screening for structural heart intervention: from the American Society of Echocardiography. J Am Soc Echocardiogr 2022;35:1-76.
Shirazi S, Golmohammadi F, Tavoosi A, Salehi M, Larti F, Sardari A, et al. Quantification of aortic valve area: comparison of different methods of echocardiography with 3-D scan of the excised valve. Int J Cardiovasc Imaging 2021;37:529-38.
Beneduce A, Capogrosso C, Moroni F, Ancona F, Falasconi G, Pannone L, et al. Aortic valve area calculation using 3D transesophageal echocardiography: implications for aortic stenosis severity grading. Echocardiography 2020;37(12):2071-81.
Cueff C, Serfaty J-M, Cimadevilla C, Laissy J-P, Himbert D, Tubach F, et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 2011;97:721-6.
Pawade T, Clavel M-A, Tribouilloy C, Dreyfus J, Mathieu T, Tastet L, et al. Computed tomography aortic valve calcium scoring in patients with aortic stenosis. Circ Cardiovasc Imaging 2018;11(3):e007146.
Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, et al. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 2021;77:128-39.
Bonelli A, Paris S, Nardi M, Henein MY, Agricola E, Troise G, et al. Aortic valve stenosis and cardiac amyloidosis: a misleading association. J Clin Med 2021;10:4234.
Anderson RH. Clinical anatomy of the aortic root. Heart 2000;84:670-3.
Maeno Y, Abramowitz Y, Kawamori H, Kazuno Y, Kubo S, Takahashi N, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging 2017;10:1139-47.
Chieffo A, Giustino G, Spagnolo P, Panoulas VF, Montorfano M, Latib A, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv 2015;8:e002025.
Suchá D, Tuncay V, Prakken NHJ, Leiner T, van Ooijen PMA, Oudkerk M, et al. Does the aortic annulus undergo conformational change throughout the cardiac cycle? A systematic review. Eur Hear J Cardiovasc Imaging 2015;16(12):1307-17.
Wang DD, Qian Z, Vukicevic M, Engelhardt S, Kheradvar A, Zhang C, et al. 3D printing, computational modeling, and artificial intelligence for structural heart disease. JACC Cardiovasc Imaging 2021;14:41-60.
Prihadi EA, van Rosendael PJ, Vollema EM, Bax JJ, Delgado V, Ajmone Marsan N. Feasibility, accuracy, and reproducibility of aortic annular and root sizing for transcatheter aortic valve replacement using novel automated three-dimensional echocardiographic software: comparison with multi-detector row computed tomography. J Am Soc Echocardiogr 2018;31:505-514.e3.
Stella S, Italia L, Geremia G, Rosa I, Ancona F, Marini C, et al. Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection. Eur Hear J Cardiovasc Imaging 2019;20:45-55.
Ruile P, Blanke P, Krauss T, Dorfs S, Jung B, Jander N, et al. Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. Eur Hear J Cardiovasc Imaging 2016;17:458-66.
Bleiziffer S, Krane M, Deutsch MA, Elhmidi Y, Piazza N, Voss B, et al. Which way in? The necessity of multiple approaches to transcatheter valve therapy. Curr Cardiol Rev 2014; 9:268-73.
Linke A, Wenaweser P, Gerckens U, Tamburino C, Bosmans J, Bleiziffer S, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J 2014;35:2672-84.
Blakeslee-Carter J, Dexter D, Mahoney P, Ahanchi S, Steerman S, Larion S, et al. A novel iliac morphology score predicts procedural mortality and Major vascular complications in transfemoral aortic valve replacement. Ann Vasc Surg 2018;46:208-17.
Ludman PF, Moat N, de Belder MA, Blackman DJ, Duncan A, Banya W, et al. Transcatheter aortic valve implantation in the United Kingdom. Circulation 2015; 131:1181-90.
Pascual I, Carro A, Avanza P, Hernández-Vaquero D, Díaz R, Rozado J, et al. Vascular approaches for transcatheter aortic valve implantation. J Thorac Dis 2017;9:S478-87.
Petronio AS, de Carlo M, Bedogni F, Maisano F, Ettori F, Klugmann S, et al. 2-year results of CoreValve implantation through the subclavian access. J Am Coll Cardiol 2012; 60:502-7.
De Palma R, Settergren M, Rück A, Svensson A, Feldt K, Saleh N. A path to avoid during transcatheter aortic valve implantation: case report. Radiology 2016;280:58-61.
Petronio AS, de Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010;3:359-66.
Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, et al. Expanding the eligibility for transcatheter aortic valve implantation. JACC Cardiovasc Interv 2009;2:828-33.
Blanke P, Naoum C, Dvir D, Bapat V, Ong K, Muller D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation. JACC Cardiovasc Imaging 2017;10:482-5.
Bruschi G, de Marco F, Botta L, Cannata A, Oreglia J, Colombo P, et al. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation. Ann Thorac Surg 2012;94:497-503.
Bapat VN, Attia RQ, Thomas M. Distribution of calcium in the ascending aorta in patients undergoing transcatheter aortic valve implantation and its relevance to the transaortic approach. JACC Cardiovasc Interv 2012;5:470-6.
Gammie JS, Bartus K, Gackowski A, D'Ambra MN, Szymanski P, Bilewska A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. J Am Coll Cardiol 2018;71:25-36.
Halabi M, Ratnayaka K, Faranesh AZ, Chen MY, Schenke WH, Lederman RJ. Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions. J Am Coll Cardiol 2013;61:1745-6.
Modine T, Sudre A, Delhaye C, Fayad G, Lemesle G, Collet F, et al. Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes. Ann Thorac Surg 2012;93:1489-94.
Wee IJY, Stonier T, Harrison M, Choong AMTL. Transcarotid transcatheter aortic valve implantation: a systematic review. J Cardiol 2018;71:525-33.
Mylotte D, Sudre A, Teiger E, Obadia JF, Lee M, Spence M, et al. Transcarotid transcatheter aortic valve replacement. JACC Cardiovasc Interv 2016;9:472-80.
Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-5.
Jilaihawi H, Chen M, Webb J, Himbert D, Ruiz CE, Rodés-Cabau J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging 2016;9: 1145-58.
Jilaihawi H, Makkar RR, Kashif M, Okuyama K, Chakravarty T, Shiota T, et al. A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Hear journal Cardiovasc Imaging 2014;15:1324-32.
Tchetche D, Siddiqui S. Percutaneous management of bicuspid aortic valves: still remaining questions. JACC Cardiovasc Interv 2020;13:1760-2.
Iannopollo G, Romano V, Buzzatti N, de Backer O, Søndergaard L, Merkely B, et al. A novel supra-annular plane to predict TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane. EuroIntervention 2020;16:259-61.
Ueshima D, Nai Fovino L, Brener SJ, Fabris T, Scotti A, Barioli A, et al. Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: a systematic review and meta-analysis. Int J Cardiol 2020; 298:76-82.
Costa G, Angelillis M, Petronio AS. Bicuspid valve sizing for transcatheter aortic valve implantation: the missing link. Front Cardiovasc Med 2022;8:770924.
Petronio AS, Angelillis M, De Backer O, Giannini C, Costa G, Fiorina C, et al. Bicuspid aortic valve sizing for transcatheter aortic valve implantation: development and validation of an algorithm based on multi-slice computed tomography. J Cardiovasc Comput Tomogr 2020;14:452-61.
Iannopollo G, Romano V, Esposito A, Guazzoni G, Ancona M, Ferri L, et al. Update on supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease according to the LIRA method. Eur Hear J Suppl 2022;24:C233-42.
Maeno Y, Yoon S-H, Abramowitz Y, Watanabe Y, Jilaihawi H, Lin M-S, et al. Effect of ascending aortic dimension on acute procedural success following self-expanding transcatheter aortic valve replacement: a multicenter retrospective analysis. Int J Cardiol 2017;244:100-5.
Arias EA, Bhan A, Lim ZY, Mullen M. TAVI for pure native aortic regurgitation: are we there yet? Interv Cardiol Rev 2019;14:26-30.
Alkhouli M, Sengupta P, Badhwar V. Toward precision in balloon-expandable TAVR: oversizing tight versus just right. JACC Cardiovasc Interv 2017;10:821-3.
Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366: 1705-15.
Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, et al. 2012 ACCF/ AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 2012;144:e29-84.
Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis. J Am Coll Cardiol 2017;69:1313-46.
Dvir D, Jhaveri R, Pichard AD. The minimalist approach for transcatheter aortic valve replacement in high-risk patients. JACC Cardiovasc Interv 2012;5:468-9.
Zamorano JL, Badano LP, Bruce C, Chan K-L, Goncalves A, Hahn RT, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011;32:2189-214.
Stella S, Melillo F, Capogrosso C, Fisicaro A, Ancona F, Latib A, et al. Intra-procedural monitoring protocol using routine transthoracic echocardiography with backup trans-oesophageal probe in transcatheter aortic valve replacement: a single centre experience. Eur Hear J Cardiovasc Imaging 2020;21:85-92.
VARC-3 Writing Committee, Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J 2021;42:1825-57.
Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian. Eur Hear J Cardiovasc Imaging 2016;17:589-90.
Hahn RT, Pibarot P, Weissman NJ, Rodriguez L, Jaber WA. Assessment of paravalvular aortic regurgitation after transcatheter aortic valve replacement: intra-core laboratory variability. J Am Soc Echocardiogr 2015;28:415-22.
Kitamura M, Majunke N, Holzhey D, Desch S, Bani Hani A, Krieghoff C, et al. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique. EuroIntervention 2020;16:682-90.
Protsyk V, Meineri M, Kitamura M, Flo Forner A, Holzhey D, Thiele H, et al. Echocardiographic guidance of intentional leaflet laceration prior to transcatheter aortic valve replacement: a structured approach to the bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction proc. J Am Soc Echocardiogr 2021;34(6):676-89.
Buzzatti N, Romano V, De Backer O, Soendergaard L, Rosseel L, Maurovich-Horvat P, et al. Coronary access after repeated transcatheter aortic valve implantation. JACC Cardiovasc Imaging 2020;13:508-15.
Barbanti M, Costa G, Picci A, Criscione E, Reddavid C, Valvo R, et al. Coronary cannulation after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2020;13: 2542-55.
Søndergaard L. Transcatheter aortic valve implantation: don't forget the coronary arteries! EuroIntervention 2018;14:147-9.
Tsuruta H, Hayashida K, Yashima F, Yanagisawa R, Tanaka M, Arai T, et al. Incidence, predictors, and midterm clinical outcomes of left ventricular obstruction after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2018;92:E288-98.
Jørgensen TH, Thyregod HGH, Ihlemann N, Nissen H, Petursson P, Kjeldsen BJ, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021;42: 2912-9.
Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol 2019;73:537-45.
Lancellotti P, Martinez C, Radermecker M. The long quest for the holy grail in transcatheter aortic bioprosthesis. J Am Coll Cardiol 2019;73:554-8.
Shames S, Koczo A, Hahn R, Jin Z, Picard MH, Gillam LD. Flow characteristics of the SAPIEN aortic valve: the importance of recognizing in-stent flow acceleration for the echocardiographic assessment of valve function. J Am Soc Echocardiogr 2012;25:603-9.
De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, et al. Reduced leaflet motion after transcatheter aortic-valve replacement. N Engl J Med 2020;382:130-9.
Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet 2017;389:2383-92.
Latib A, Messika-Zeitoun D, Maisano F, Himbert D, Agricola E, Brochet E, et al. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 2013;61:787-9.
Spartera M, Ancona F, Barletta M, Rosa I, Stella S, Marini C, et al. Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis. Echocardiography 2018;35:337-45.
Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Hear J Cardiovasc Imaging 2017;18:254-75.
Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P. Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging 2016;9:924-33.
Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 2015;373:2015-24.
Jabbour RJ, Tanaka A, Colombo A, Latib A. Delayed coronary occlusion after transcatheter aortic valve implantation: implications for new transcatheter heart valve design and patient management. Interv Cardiol (London, England) 2018;13:137-9.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/ EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43: 561-632.
Lancellotti P, Zamorano JL, Habib G, Badano L, eds. The EACVI Textbook of Echocardiography. EACVI Textb. Echocardiogr. Oxford, UK: Oxford University Press; 2016.
Sutaria N, Northridge DB, Shaw TR. Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart 2000;84:398-402.
Padial LR, Freitas N, Sagie A, Newell JB, Weyman AE, Levine RA, et al. Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. J Am Coll Cardiol 1996;27:1225-31.
Min S-Y, Song J-M, Kim Y-J, Park H-K, Seo M-O, Lee M-S, et al. Discrepancy between mitral valve areas measured by two-dimensional planimetry and three-dimensional transoesophageal echocardiography in patients with mitral stenosis. Heart 2013;99: 253-8.
Anwar AM, Attia WM, Nosir YFM, Soliman OII, Mosad MA, Othman M, et al. Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography. J Am Soc Echocardiogr 2010;23:13-22.
Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2016;17:1191-229.
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. EAE/ ASE. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
El Sabbagh A, Reddy YNV, Barros-Gomes S, Borlaug BA, Miranda WR, Pislaru SV, et al. Low-gradient severe mitral stenosis: hemodynamic profiles, clinical characteristics, and outcomes. J Am Heart Assoc 2019;8(5):e010736.
Spagnolo P, Giglio M, Di Marco D, Cannaò PM, Agricola E, Bella PE, et al. Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT. Eur Radiol 2021;31:1236-44.
Writing Committee Members; Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77:450-500.
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91.
Wunderlich NC, Beigel R, Siegel RJ. Management of mitral stenosis using 2D and 3D echo-Doppler imaging. JACC Cardiovasc Imaging 2013;6:1191-205.
Messika-Zeitoun D, Brochet E, Holmin C, Rosenbaum D, Cormier B, Serfaty J-M, et al. Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. Eur Heart J 2007;28:72-9.
Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 1993;21:390-7.
Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308.
Iung B, Cormier B, Ducimetière P, Porte JM, Nallet O, Michel PL, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation 1996;94:2124-30.
Faletra FF, Perk G, Pandian NG, Nesser H-J, Kronzon I. Real-Time 3D Interventional Echocardiography. London: Springer London; 2014.
Nunes MCP, Tan TC, Elmariah S, do Lago R, Margey R, Cruz-Gonzalez I, et al. The echo score revisited: impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty. Circulation 2014;129:886-95.
Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D, et al. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation 2012;125:2119-27.
Dreyfus J, Cimadevilla C, Nguyen V, Brochet E, Lepage L, Himbert D, et al. Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. Eur Heart J 2014;35:1617-23.
Sharma A, Kelly R, Mbai M, Chandrashekhar Y, Bertog S. Transcatheter mitral valve lithotripsy as a pretreatment to percutaneous balloon mitral valvuloplasty for heavily calcified rheumatic mitral stenosis. Circ Cardiovasc Interv 2020;13(7):e009357.
Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002;105:1465-71.
Kronzon I, Glassman E, Cohen M, Winer H. Use of two-dimensional echocardiography during transseptal cardiac catheterization. J Am Coll Cardiol 1984;4:425-8.
Pandian NG, Isner JM, Hougen TJ, Desnoyers MR, McInerney K, Salem DN. Percutaneous balloon valvuloplasty of mitral stenosis aided by cardiac ultrasound. Am J Cardiol 1987;59:380-1.
Agricola E. Interventional echocardiography. Edizioni Minerva Medica 2020.
Rao AS, Murthy RS, Naidu PB, Raghu K, Anjaneyulu AV, Raju PK, et al. Transesophageal echocardiography for the detection of left atrial thrombus. Indian Heart J 1994;46: 37-40.
Alkhouli M, Rihal CS, Holmes DR. Transseptal techniques for emerging structural heart interventions. JACC Cardiovasc Interv 2016;9:2465-80.
Applebaum RM, Kasliwal RR, Kanojia A, Seth A, Bhandari S, Trehan N, et al. Utility of three-dimensional echocardiography during balloon mitral valvuloplasty. J Am Coll Cardiol 1998;32:1405-9.
Messika-Zeitoun D, Blanc J, Iung B, Brochet E, Cormier B, Himbert D, et al. Impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome. JACC Cardiovasc Imaging 2009;2:1-7.
Thomas JD, Wilkins GT, Choong CY, Abascal VM, Palacios IF, Block PC, et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation 1988;78:980-93.
Zamorano J, Perez de Isla L, Sugeng L, Cordeiro P, Rodrigo JL, Almeria C, et al. Non-invasive assessment of mitral valve area during percutaneous balloon mitral valvuloplasty: role of real-time 3D echocardiography. Eur Heart J 2004;25:2086-91.
Vilacosta I, Iturralde E, San Román JA, Gómez-Recio M, Romero C, Jiménez J, et al. Transesophageal echocardiographic monitoring of percutaneous mitral balloon valvulotomy. Am J Cardiol 1992;70:1040-4.
Salem MI, Makaryus AN, Kort S, Chung E, Marchant D, Ong L, et al. Intracardiac echocardiography using the AcuNav ultrasound catheter during percutaneous balloon mitral valvuloplasty. J Am Soc Echocardiogr 2002;15:1533-7.
Marmagkiolis K, Cilingiroglu M. Intracardiac echocardiography-guided percutaneous mitral balloon valvuloplasty. Rev Port Cardiol 2013;32:337-9.
Bartel T, Müller S, Biviano A, Hahn RT. Why is intracardiac echocardiography helpful? Benefits, costs, and how to learn. Eur Heart J 2014;35:69-76.
Bouleti C, Iung B, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, et al. Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy. Heart 2013;99:1336-41.
Kim J-B, Ha J-W, Kim J-S, Shim W-H, Kang S-M, Ko Y-G, et al. Comparison of long-term outcome after mitral valve replacement or repeated balloon mitral valvotomy in patients with restenosis after previous balloon valvotomy. Am J Cardiol 2007;99: 1571-4.
Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, et al. Contemporary presentation and management of valvular heart disease. Circulation 2019;140:1156-69.
Cahill TJ, Prothero A, Wilson J, Kennedy A, Brubert J, Masters M, et al. Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation. Heart 2021;107:1003-9.
Lancellotti P, Pibarot P, Chambers J, La Canna G, Pepi M, Dulgheru R, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Hear J Cardiovasc Imaging 2022;23:e171-232.
Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation. J Am Coll Cardiol 2015;66:2844-54.
Lim DS, Kar S, Spargias K, Kipperman RM, O'Neill WW, Ng MKC et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study. JACC Cardiovasc Interv 2019;12(14):1369-78.
Obadia J-F, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297-306.
Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307-18.
Taramasso M, Latib A. Percutaneous mitral annuloplasty. Interv Cardiol Clin 2016;5: 101-7.
Mangieri A, Colombo A, Demir OM, Agricola E, Ancona F, Regazzoli D, et al. Percutaneous direct annuloplasty with edge-to-edge technique for mitral regurgitation: replicating a complete surgical mitral repair in a one-step procedure. Can J Cardiol 2018;34(8):1088.e1-e2.
Latib A, Ancona MB, Ferri L, Montorfano M, Mangieri A, Regazzoli D, et al. Percutaneous direct annuloplasty with Cardioband to treat recurrent mitral regurgitation after MitraClip implantation. JACC Cardiovasc Interv 2016;9(18):e191-2.
Nickenig G, Hammerstingl C, Schueler R, Topilsky Y, Grayburn PA, Vahanian A, et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation. JACC Cardiovasc Interv 2016;9:2039-47.
Messika-Zeitoun D, Nickenig G, Latib A, Kuck K-H, Baldus S, Schueler R, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J 2019;40:466-72.
Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, et al. The international multicenter TriValve registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc Interv 2017;10:1982-90.
Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail 2012;14:931-8.
Tops LF, van de Veire NR, Schuijf JD, de Roos A, van der Wall EE, Schalij MJ, et al. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus. Circulation 2007;115:1426-32.
Mischke K, Knackstedt C, Mühlenbruch G, Schimpf T, Neef P, Zarse M, et al. Imaging of the coronary venous system: retrograde coronary sinus angiography versus venous phase coronary angiograms. Int J Cardiol 2007;119:339-43.
Choure AJ, Garcia MJ, Hesse B, Sevensma M, Maly G, Greenberg NL, et al. In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography. J Am Coll Cardiol 2006;48:1938-45.
Tops LF, Wood DA, Delgado V, Schuijf JD, Mayo JR, Pasupati S, et al. Noninvasive evaluation of the aortic root with multislice computed tomography. JACC Cardiovasc Imaging 2008;1:321-30.
Colli A, Besola L, Montagner M, Azzolina D, Soriani N, Manzan E, et al. Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation. Int J Cardiol 2018;257:235-7.
Colli A, Zucchetta F, Torregrossa G, Manzan E, Bizzotto E, Besola L, et al. Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg 2015;4:295-7.
Colli A, Manzan E, Zucchetta F, Sarais C, Pittarello D, Gerosa G. Feasibility of anterior mitral leaflet flail repair with transapical beating-heart neochord implantation. JACC Cardiovasc Interv 2014;7:1320-1.
Gerosa G, D'Onofrio A, Manzan E, Besola L, Bizzotto E, Zucchetta F, et al. One-stage off-pump transapical mitral valve repair and aortic valve replacement. Circulation 2015; 131:e430-4.
Gammie JS, Bartus K, Gackowski A, D'Ambra MN, Szymanski P, Bilewska A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device. J Am Coll Cardiol 2018;71:25-36.
De Bonis M, Lapenna E, La Canna G, Ficarra E, Pagliaro M, Torracca L, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy. Circulation 2005;112(9 Suppl):I402-8.
Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 2013;62(12):1052-61.
Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients. J Am Coll Cardiol 2014;64: 172-81.
Praz F, Spargias K, Chrissoheris M, Büllesfeld L, Nickenig G, Deuschl F, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 2017;390(10096):773-80.
Biner S, Perk G, Kar S, Rafique AM, Slater J, Shiota T, et al. Utility of combined two-dimensional and three-dimensional transesophageal imaging for catheter-based mitral valve clip repair of mitral regurgitation. J Am Soc Echocardiogr 2011;24:611-7.
Kahlert P, Plicht B, Schenk IM, Janosi R-A, Erbel R, Buck T. Direct assessment of size and shape of noncircular vena contracta area in functional versus organic mitral regurgitation using real-time three-dimensional echocardiography. J Am Soc Echocardiogr 2008;21:912-21.
Avenatti E, Mackensen GB, El-Tallawi KC, Reisman M, Gruye L, Barker CM, et al. Diagnostic value of 3-dimensional vena contracta area for the quantification of residual mitral regurgitation after MitraClip procedure. JACC Cardiovasc Interv 2019;12:582-91.
Zoghbi WA, Asch FM, Bruce C, Gillam LD, Grayburn PA, Hahn RT, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement. J Am Soc Echocardiogr 2019;32(4):431-75.
Agricola E, Meucci F, Ancona F, Pardo Sanz A, Zamorano JL. Echocardiographic guidance in transcatheter structural cardiac interventions. EuroIntervention 2022;17: 1205-26.
Maisano F, Redaelli A, Pennati G, Fumero R, Torracca L, Alfieri O. The hemodynamic effects of double-orifice valve repair for mitral regurgitation: a 3D computational model1. Eur J Cardio-Thoracic Surg 1999;15:419-25.
Sürder D, Pedrazzini G, Gaemperli O, Biaggi P, Felix C, Rufibach K, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 2013;99(14):1034-40.
Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, et al. EVEREST Investigators. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention 2009;4:437-42.
Singh GD, Smith TW, Rogers JH. Multi-MitraClip therapy for severe degenerative mitral regurgitation: "anchor" technique for extremely flail segments. Catheter Cardiovasc Interv 2015;86:339-46.
Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014;64: 182-92.
Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, et al. Percutaneous mitral repair with the MitraClip system. Safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54(8):686-94.
Kreidel F, Frerker C, Schlüter M, Alessandrini H, Thielsen T, Geidel S, et al. Repeat MitraClip therapy for significant recurrent mitral regurgitation in high surgical risk patients. JACC Cardiovasc Interv 2015;8:1480-9.
Neuss M, Schau T, Isotani A, Pilz M, Schöpp M, Butter C. Elevated mitral valve pressure gradient after MitraClip implantation deteriorates long-term outcome in patients with severe mitral regurgitation and severe heart failure. JACC Cardiovasc Interv 2017;10: 931-9.
Faletra FF, Pozzoli A, Agricola E, Guidotti A, Biasco L, Leo LA, et al. Echocardiographic-fluoroscopic fusion imaging for transcatheter mitral valve repair guidance. Eur Heart J Cardiovasc Imaging 2018;19:715-26.
Melillo F, Fisicaro A, Stella S, Ancona F, Capogrosso C, Ingallina G, et al. Systematic fluoroscopic-echocardiographic fusion imaging protocol for transcatheter edge-to-edge mitral valve repair intraprocedural monitoring. J Am Soc Echocardiogr 2021;34:604-13.
Foster E, Wasserman HS, Gray W, Homma S, Di Tullio MR, Rodriguez L, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100: 1577-83.
Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, et al. Percutaneous mitral valve edge-to-edge repair. J Am Coll Cardiol 2014;64: 875-84.
Altiok E, Paetsch I, Jahnke C, Brehmer K, Reith S, Becker M, et al. Percutaneous edge-to-edge mitral valve repair. J Am Coll Cardiol 2011;58:e21.
Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG, et al. Echocardiographic outcomes after transcatheter leaflet approximation in patients with secondary mitral regurgitation. J Am Coll Cardiol 2019;74:2969-79.
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation. J Am Soc Echocardiogr 2017;30:303-71.
Halaby R, Herrmann HC, Gertz ZM, Lim S, Kar S, Lindenfeld J, et al. Effect of mitral valve gradient after MitraClip on outcomes in secondary mitral regurgitation. JACC Cardiovasc Interv 2021;14:879-89.
Taramasso M, Kuwata S, Rodriguez H, Biefer C, Nietlispach F, Maisano F. Percutaneous mitral valve repair and replacement: complementary or competitive techniques? EuroIntervention 2016;12:Y97-Y101.
Maisano F, Alfieri O, Banai S, Buchbinder M, Colombo A, Falk V, et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J 2015;36:1651-9.
Blanke P, Naoum C, Dvir D, Bapat V, Ong K, Muller D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the neo-LVOT. JACC Cardiovasc Imaging 2017;10:482-5.
Gheorghe LL, Mobasseri S, Agricola E, Wang DD, Milla F, Swaans M, et al. Imaging for native mitral valve surgical and transcatheter interventions. JACC Cardiovasc Imaging 2021;14:112-27.
Kreidel F, Zaid S, Tamm AR, Ruf TF, Beiras-Fernandez A, Reinold J, et al. Impact of mitral annular dilation on edge-to-edge therapy with MitraClip-XTR. Circ Cardiovasc Interv 2021;14(8):e010447.
